Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver
- PMID: 16609999
- PMCID: PMC4087518
- DOI: 10.3748/wjg.v12.i12.1918
Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver
Abstract
Aim: To study the effects of interleukin-10 (IL-10) on the expression of alpha-smooth muscle actin (alpha-SMA), nuclear factor- kappa B(NF- kappa B) and Fas/Fas ligand (FasL) in hepatic stellate cells of experimental rats with hepatic fibrosis.
Methods: Sixty clean SD rats were randomly divided into control group (group N), liver fibrotic group (group C) and IL-10 treatment group (group I). Control group received intraperitoneal injection of saline (2 mL/kg), twice a week. Fibrotic group was injected intraperitoneally with 50% carbon tetrachloride (CCl(4)) (2 mL/kg), twice a week. IL-10 treatment group was given IL-10 at a dose of 4 microg/kg 20 minutes before CCl(4) administration from the third week. Hepatic stellate cells (HSCs) were isolated from these rats at the seventh and eleventh weeks during the course of liver fibrosis, respectively. The expression of alpha-SMA and NF- kappa B in HSCs was measured by S-P immunohistochemistry. The expression of Fas and FasL mRNA was measured by RT-PCR. Furthermore, liver tissues were harvested from three groups at the same time.
Results: The CCl(4)- induced experimental rat hepatic fibrosis model was established successfully. The purity of extracted hepatic stellate cells was about 95% and the yield of hepatic stellate cells was 1.2-2.3 x 10(6)/g liver tissue averagely. The positive expression of alpha-SMA and NF- kappa B was 36.5% and 28.5% respectively in group N. The positive levels of alpha-SMA and NF- kappa B were increased significantly in group C compared to group N (P<0.01). The positive signals decreased significantly (P<0.05) in group I. In the 11th week, the HSCs of group I became round with visible pyknotic nuclei. The expression of NF- kappa B in group C was significantly increased in a time-dependent manner (P<0.01), but there was no difference in the alpha-SMA expression (P>0.05). The mRNA of Fas and FasL in group C was significantly increased in a time-dependent manner compared to that in control group. After treated with IL-10, the expression level of Fas and FasL was higher in group I than in group C.
Conclusion: The positive expression of alpha-SMA and NF- kappa B in hepatic stellate cells is decreased by ectogenic IL-10 in liver fibrosis induced by CCl(4). The expression of Fas and FasL is increased in the course of liver fibrosis, and is further increased by IL-10. IL-10 could inhibit the activation of HSCs and cause apoptosis of activated HSCs.
Figures




Similar articles
-
The effects of interleukin-10 on the expression of Fas and FasL in rat hepatic stellate cells.Med Chem. 2006 Nov;2(6):611-6. doi: 10.2174/1573406410602060611. Med Chem. 2006. PMID: 17105443
-
Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro.World J Gastroenterol. 2004 Sep 15;10(18):2706-10. doi: 10.3748/wjg.v10.i18.2706. World J Gastroenterol. 2004. PMID: 15309723 Free PMC article.
-
Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10.World J Gastroenterol. 2006 Apr 21;12(15):2357-62. doi: 10.3748/wjg.v12.i15.2357. World J Gastroenterol. 2006. PMID: 16688825 Free PMC article.
-
18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells.Med Sci Monit. 2012 Jan;18(1):BR24-32. doi: 10.12659/msm.882196. Med Sci Monit. 2012. PMID: 22207106 Free PMC article.
-
Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.Med Sci Monit. 2021 Aug 20;27:e931236. doi: 10.12659/MSM.931236. Med Sci Monit. 2021. PMID: 34413280 Free PMC article.
Cited by
-
The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis.Adv Wound Care (New Rochelle). 2020 Apr 1;9(4):184-198. doi: 10.1089/wound.2019.1032. Epub 2020 Feb 7. Adv Wound Care (New Rochelle). 2020. PMID: 32117582 Free PMC article. Review.
-
Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer.J Cancer. 2020 Jan 14;11(6):1505-1515. doi: 10.7150/jca.38616. eCollection 2020. J Cancer. 2020. PMID: 32047557 Free PMC article. Review.
-
Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis.Front Pharmacol. 2021 Mar 24;12:645703. doi: 10.3389/fphar.2021.645703. eCollection 2021. Front Pharmacol. 2021. PMID: 33841164 Free PMC article. Review.
-
Pancreatic stellate cells: Key players in pancreatic health and diseases (Review).Mol Med Rep. 2024 Jul;30(1):109. doi: 10.3892/mmr.2024.13233. Epub 2024 May 2. Mol Med Rep. 2024. PMID: 38695254 Free PMC article. Review.
-
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives.Int J Pharm. 2024 Jul 20;660:124381. doi: 10.1016/j.ijpharm.2024.124381. Epub 2024 Jun 23. Int J Pharm. 2024. PMID: 38917958 Free PMC article. Review.
References
-
- Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247–2250. - PubMed
-
- Safadi R, Friedman SL. Hepatic fibrosis--role of hepatic stellate cell activation. MedGenMed. 2002;4:27. - PubMed
-
- Rockey DC. The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications. Clin Liver Dis. 2000;4:319–355. - PubMed
-
- Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001;21:437–451. - PubMed
-
- Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, Timpl R, Ramadori G. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol. 1999;112:387–401. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous